Browse All

Current Filters

CLEAR FILTER x

TITLE

Phase 3, Open-Label, Multicenter Safety Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (MT-1186-A01): 48-Week Results

Author:Genge, Angela   Pattee, Gary   Sobue, Gen   Couratier, Philippe   Selness, Daniel   Bidani, Sachin   Hirai, Manabu   Sakata, Takeshi   Salah, Alejandro   Apple, Stephen   

Session Name:P6: General Neurology: New Treatments  

Topic:General Neurology  

Program Number:P6.001  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  University of Nebraska Medical Center, Lincoln, NE  Nagoya University Graduate School of Medicine, Nagoya, Japan  CRMR SLA Service de Neurologie, CHU de Limoges, Limoges, France  Mitsubishi Tanabe Pharma Development America, Inc. , Jersey City, NJ  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  

Is ALS Onset Accelerated by Chloroviruses and Delayed by Antiviral Immune Responses?

Author:Pattee, Gary   Petro, Tom   Esmael, Ahmed   Irina, Agarkova   Dunigan, David   Van Etten, James   

Session Name:P8: Neuromuscular Disease: Amyotrophic Lateral Sclerosis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P8.001  

Author Institution:BMH Physicians Network, Lincoln, NE  University of Nebraska Medical Center, Lincoln, NE  University of Nebraska, Lincoln, NE